Bokus

Roy J. Vaz – författare

Visar alla böcker från författaren Roy J. Vaz. Handla med fri frakt och snabb leverans.

4 produkter

  1. Laszlo Urban, Laszlo Urban, Vinod Patel, Roy J. Vaz - Antitargets and Drug Safety, Inbunden. Tillgänglighet: Lägg i varukorg

    Antitargets and Drug Safety

    Av Laszlo Urban, Laszlo Urban m. fl.

    Inbunden, 2015

    2011 kr

    Lägg i varukorg

    With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future.Divided into three major parts, the first section deals with novel technologies and includes the utility of …

  2. Thomas Klabunde, Roy J. Vaz - Antitargets, E-bok. Tillgänglighet: Lägg i varukorg

    Antitargets

    Prediction and Prevention of Drug Side Effects

    Av Thomas Klabunde, Roy J. Vaz

    E-bok, 2008

    3273 kr

    Lägg i varukorg

    This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies …

  3. Roy J. Vaz, Vinod Patel, Laszlo Urban - Antitargets and Drug Safety, E-bok. Tillgänglighet: Lägg i varukorg

    Antitargets and Drug Safety

    Av Roy J. Vaz, Vinod Patel m. fl.

    E-bok, 2015

    2248 kr

    Lägg i varukorg

    With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of …

  4. Roy J. Vaz, Vinod Patel, Laszlo Urban - Antitargets and Drug Safety, E-bok. Tillgänglighet: Lägg i varukorg

    Antitargets and Drug Safety

    Av Roy J. Vaz, Vinod Patel m. fl.

    E-bok, 2015

    2298 kr

    Lägg i varukorg

    With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of …